oncology
Medicines

Gender may impact immunotherapy response

The gender of a cancer patient may have an impact on how well immunotherapy works,  a large meta-analysis published in The Lancet Oncology reports. According to the authors from the Division of Medical Oncology for Melanoma and Sarcoma at the Institute of Oncology in Milan the findings highlight the need for gender-specific analyses to avoid “erroneously ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic